Top compounds associated with response to TMEM91


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA bid1870 gCSI pan-cancer AAC 0.031 0.6
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.019 0.6
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.042 0.6
mRNA JW-480 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA lapatinib gCSI pan-cancer AAC -0.029 0.6
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.055 0.6
mRNA BEC CTRPv2 pan-cancer AAC 0.04 0.6
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV